← Explorer/Network

Genome-Wide Transposon Mutagenesis of Borrelia burgdorferi for Identification of Phenotypic Mutants

Stewart PE, Hoff J, Fischer E +2 more2004Applied and Environmental MicrobiologyJournal Article
10.1128/aem.70.10.5973-5979.2004PubMedFree full text
CardiovascularMusculoskeletalNeurological
Lyme & Co-Infections

Abstract

ABSTRACT The spirochete Borrelia burgdorferi is the causative agent of Lyme disease, the leading vector-borne illness in the United States. Many of the genetic factors affecting spirochete morphology and physiology are unknown due to the limited genetic tools available and the large number of open reading frames with unknown functions. By adapting a mariner transposon to function in B. burgdorferi , we have developed a random mutagenesis system that tags the mutated locus for rapid identification. Transposition occurs at saturating levels in B. burgdorferi and appears to be random, targeting both linear and circular replicons. By combining the transposon system with a screen for factors affecting growth rate, mutations were readily identified in genes putatively involved in cell division and chemotaxis and a hypothetical open reading frame involved in outer membrane integrity. The successful adaptation of a mariner transposon to function in B. burgdorferi should aid in identifying virulence factors and novel gene products related to spirochete physiology.

Cited By (1)

  • Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme diseaseClinical Infectious Diseases · 2007

Related Papers

  • Fibronectin binding protein BBK32 of the lyme disease spirochete promotes bacterial attachment to glycosaminoglycansInfection and Immunity · 2006 · 4 shared tags
  • Do babesiosis and malaria share a common disease processAnnals of Tropical Medicine and Parasitology · 1998 · 4 shared tags
  • Lyme disease and babesiosis: acaricide focused on potentially infected ticksAmerican Journal of Tropical Medicine and Hygiene · 1987 · 4 shared tags
  • The Emergence of Lyme Disease and Human Babesiosis in a Changing EnvironmentaAnnals of the New York Academy of Sciences · 1994 · 4 shared tags
  • Tetracycline therapy for chronic Lyme Disease. Clinical Infectious Disease 25 Suppl 1: S52-6 19931993 · 4 shared tags
  • Lyme Disease. NEJM 321 (9) : 586-96 19891989 · 4 shared tags